MyChesCo on MSN7h
FDA Approves Breakthrough Eye Therapy and Expands Life-Saving Allergy Spray for Kids
The U.S. Food and Drug Administration (FDA) has announced significant advancements in medical treatments, including the ...
Targeted Oncology1d
Exploring Fixed-Duration Ibrutinib and Venetoclax in CLL Treatment
Paolo Ghia, MD, PhD, discusses the CAPTIVATE trial in chronic lymphocytic leukemia/small lymphocytic lymphoma, and what findings from the trial have been particularly noteworthy.
Rheumatology Advisor2d
Filgotinib Maintains Long-Term Safety and Efficacy in Rheumatoid Arthritis Treatment
Filgotinib maintained a favorable safety and efficacy profile for up to 8 years among patients with RA who participated in the DARWIN 3 LTE.
The New England Journal of Medicine3d
Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis
Bacterial vaginosis affects one third of reproductive-aged women, and recurrence is common. Evidence of sexual exchange of ...